New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Auxly Cannabis Group Inc.
XLY.TO
Shape
US Flag

TSX

Unprofitable

EPS improving

Unprofitable

EPS improving

51M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Nov 2024

51M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Nov 2024

0.04CAD
Shape-0.01 ( -11.11%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-26%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

43%

Quote Panel

Shape
Updated October 16, 2024
1W 28.57 % 1M 28.57 % 3M 50.00 % 1Y 200.00 %

Key Metrics

Shape
  • Market Cap

    51.38M


  • Shares Outstanding

    1.28B


  • Share in Float

    995.37M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    0.04


  • Average Volume

    370373


  • Beta

    1.242


  • Range

    0.01-0.07


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://auxly.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.49x

P/S Ratio

0.50x

P/B Ratio

0.6

Debt/Equity

-41.5%

Net Margin

$-0.0

EPS

How XLY.TO compares to sector?

P/E Ratio

Relative Strength

Shape

XLY.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$126M

Shape332%

2025-Revenue

$0.01

Shape-725%

2025-EPS

$70M

Shape-6161%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.05
vs -0.01

Q2.22

arrow
arrow

N/A

-0.02
vs 0.01

Q3.22

arrow
arrow

N/A

-0.07
vs -0.02

Q4.22

arrow
arrow

N/A

-0.02
vs -0.02

Q1.23

arrow
arrow

N/A

-0.01
vs -0.05

Q2.23

arrow
arrow

N/A

-0.01
vs -0.02

Q3.23

arrow
arrow

+143%

0.03
vs -0.07

Q4.23

arrow
arrow

N/A

-0.05
vs -0.02

Q1.24

arrow
arrow

N/A

-0.03
vs -0.01

Q2.24

arrow
arrow

+115%

0
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-19%

19.8M  vs 24.5M

Q4.22

arrow
arrow

-16%

24.7M  vs 29.3M

Q1.23

arrow
arrow

+6%

24M  vs 22.6M

Q2.23

arrow
arrow

-20%

22M  vs 27.3M

Q3.23

arrow
arrow

+42%

28.2M  vs 19.8M

Q4.23

arrow
arrow

+9%

26.9M  vs 24.7M

Q1.24

arrow
arrow

+5%

25.2M  vs 24M

Q2.24

arrow
arrow

+33%

29.2M  vs 22M

Q3.24

arrow
arrow

+21%

34.2M  vs 28.2M

Q4.24

arrow
arrow

+38%

37M  vs 26.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-57%

-0.57
vs -0.09

Q4.22

arrow
arrow

-18%

-0.18
vs -0.57

Q1.23

arrow
arrow

-19%

-0.19
vs -0.18

Q2.23

arrow
arrow

-18%

-0.18
vs -0.19

Q3.23

arrow
arrow

+31%

0.31
vs -0.18

Q4.23

arrow
arrow

-106%

-1.06
vs 0.31

Q1.24

arrow
arrow

-25%

-0.25
vs -1.06

Q2.24

arrow
arrow

+2%

0.02
vs -0.25

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News